| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
XAV-939 is a Wnt/β-catenin pathway inhibitor. Since the Wnt/β-catenin pathway plays a role in brachyury expression, its inhibition can down-regulate brachyury. | ||||||
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111 promotes degradation of β-catenin, leading to inhibition of the Wnt/β-catenin pathway and potential down-regulation of brachyury. | ||||||
JW 55 | 664993-53-7 | sc-364517 sc-364517A | 10 mg 50 mg | $172.00 $726.00 | ||
JW 55 is another inhibitor of the Wnt/β-catenin pathway, which can lead to reduced brachyury expression. | ||||||
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $224.00 $940.00 | ||
Cardamonin is a natural compound that has been shown to inhibit the Wnt/β-catenin pathway, potentially reducing brachyury levels. | ||||||
PRI-724 | 1422253-38-0 | sc-507535 | 25 mg | $260.00 | ||
PRI-724 is a specific inhibitor of the interaction between β-catenin and its coactivator CBP. This can disrupt the Wnt/β-catenin pathway and down-regulate brachyury. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $182.00 $374.00 | 7 | |
FH535 is an inhibitor of both the Wnt/β-catenin and PPAR pathways. It might down-regulate brachyury through its effect on the Wnt pathway. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
LGK974 is an inhibitor of Porcupine, an enzyme necessary for Wnt ligand secretion. By inhibiting Wnt signaling, it can potentially reduce brachyury expression. | ||||||
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Wnt-C59 is a Porcupine inhibitor that can block Wnt signaling and potentially down-regulate brachyury. | ||||||
IQ-1 | 331001-62-8 | sc-202665 | 10 mg | $180.00 | 2 | |
IQ-1 is a specific inhibitor of the interaction between β-catenin and its coactivator p300. By doing so, it might reduce brachyury expression. | ||||||